CLINICAL_TRIALS
ClinicalTrials.gov record update
Window Trial of Fluorescently Labeled Nivolumab-IRDye800 (Nivo800) in High Grade Glioma (HGG)
This page presents selected fields from the linked source record. It does not add a medical interpretation.
Record identity and dates
- Source
- ClinicalTrials.gov
- Source record ID
- NCT07210632
- Title field or adapter rule
- protocolSection.identificationModule.officialTitle
- Ingested At
- 2026-04-25T22:28:21.050315+00:00
- Published At
- 2026-02-27T00:00:00+00:00
- Record Updated At
- 2026-02-27
- Timestamp Basis
- source retrieval time was not retained by the feed adapter
- Date limitation
- source retrieval time was not retained by the feed adapter
Fields recorded by this source
- protocolSection.conditionsModule.conditions
["Brain Cancer", "HGG", "Glioma", "High Grade Glioma", "High Grade Gliomas", "High Grade Glioma (III or IV)", "High Grade Glioma (HGG) of the Brain With BRAF Aberration"]- protocolSection.statusModule.lastUpdatePostDateStruct.date
"2026-02-27"- protocolSection.identificationModule.nctId
"NCT07210632"- protocolSection.identificationModule.officialTitle
"Window Trial of Fluorescently Labeled Nivolumab-IRDye800 (Nivo800) in High Grade Glioma (HGG)"- protocolSection.statusModule.overallStatus
"NOT_YET_RECRUITING"- protocolSection.designModule.phases
["EARLY_PHASE1"]- protocolSection.statusModule.resultsFirstPostDateStruct.date
""
Study condition terms
Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.
This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.